Global Point-of-care Molecular Diagnostic Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Point-of-care Molecular Diagnostic Solution market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Point-of-care Molecular Diagnostic Solution market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Point-of-care Molecular Diagnostic Solution market size and forecasts, in consumption value ($ Million), 2018-2029
Global Point-of-care Molecular Diagnostic Solution market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Point-of-care Molecular Diagnostic Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Point-of-care Molecular Diagnostic Solution market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Point-of-care Molecular Diagnostic Solution
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Point-of-care Molecular Diagnostic Solution market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, BioMerieux and Bio-Rad Laboratories, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Point-of-care Molecular Diagnostic Solution market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Point-of-care Molecular Diagnostic Solution product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Point-of-care Molecular Diagnostic Solution, with revenue, gross margin and global market share of Point-of-care Molecular Diagnostic Solution from 2018 to 2023.
Chapter 3, the Point-of-care Molecular Diagnostic Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Point-of-care Molecular Diagnostic Solution market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Point-of-care Molecular Diagnostic Solution.
Chapter 13, to describe Point-of-care Molecular Diagnostic Solution research findings and conclusion.
This report is a detailed and comprehensive analysis for global Point-of-care Molecular Diagnostic Solution market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Point-of-care Molecular Diagnostic Solution market size and forecasts, in consumption value ($ Million), 2018-2029
Global Point-of-care Molecular Diagnostic Solution market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Point-of-care Molecular Diagnostic Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Point-of-care Molecular Diagnostic Solution market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Point-of-care Molecular Diagnostic Solution
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Point-of-care Molecular Diagnostic Solution market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, BioMerieux and Bio-Rad Laboratories, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Point-of-care Molecular Diagnostic Solution market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Assays & kits
- Instruments & Analyzers
- Software & Services
- Physicians’ Offices
- Hospitals & ICUs
- Research Institutes
- Other End Users
- Abbott Laboratories
- F. Hoffmann-La Roche AG
- Becton, Dickinson and Company
- BioMerieux
- Bio-Rad Laboratories, Inc.
- Cepheid, Inc.
- Danaher Corporation
- Johnson and Johnson
- Bayer Healthcare
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Point-of-care Molecular Diagnostic Solution product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Point-of-care Molecular Diagnostic Solution, with revenue, gross margin and global market share of Point-of-care Molecular Diagnostic Solution from 2018 to 2023.
Chapter 3, the Point-of-care Molecular Diagnostic Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Point-of-care Molecular Diagnostic Solution market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Point-of-care Molecular Diagnostic Solution.
Chapter 13, to describe Point-of-care Molecular Diagnostic Solution research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Point-of-care Molecular Diagnostic Solution
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Point-of-care Molecular Diagnostic Solution by Type
1.3.1 Overview: Global Point-of-care Molecular Diagnostic Solution Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type in 2022
1.3.3 Assays & kits
1.3.4 Instruments & Analyzers
1.3.5 Software & Services
1.4 Global Point-of-care Molecular Diagnostic Solution Market by Application
1.4.1 Overview: Global Point-of-care Molecular Diagnostic Solution Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Physicians’ Offices
1.4.3 Hospitals & ICUs
1.4.4 Research Institutes
1.4.5 Other End Users
1.5 Global Point-of-care Molecular Diagnostic Solution Market Size & Forecast
1.6 Global Point-of-care Molecular Diagnostic Solution Market Size and Forecast by Region
1.6.1 Global Point-of-care Molecular Diagnostic Solution Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Point-of-care Molecular Diagnostic Solution Market Size by Region, (2018-2029)
1.6.3 North America Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
1.6.4 Europe Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
1.6.6 South America Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product and Solutions
2.1.4 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche AG
2.2.1 F. Hoffmann-La Roche AG Details
2.2.2 F. Hoffmann-La Roche AG Major Business
2.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product and Solutions
2.2.4 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
2.3 Becton, Dickinson and Company
2.3.1 Becton, Dickinson and Company Details
2.3.2 Becton, Dickinson and Company Major Business
2.3.3 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product and Solutions
2.3.4 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Becton, Dickinson and Company Recent Developments and Future Plans
2.4 BioMerieux
2.4.1 BioMerieux Details
2.4.2 BioMerieux Major Business
2.4.3 BioMerieux Point-of-care Molecular Diagnostic Solution Product and Solutions
2.4.4 BioMerieux Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioMerieux Recent Developments and Future Plans
2.5 Bio-Rad Laboratories, Inc.
2.5.1 Bio-Rad Laboratories, Inc. Details
2.5.2 Bio-Rad Laboratories, Inc. Major Business
2.5.3 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product and Solutions
2.5.4 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.6 Cepheid, Inc.
2.6.1 Cepheid, Inc. Details
2.6.2 Cepheid, Inc. Major Business
2.6.3 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product and Solutions
2.6.4 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cepheid, Inc. Recent Developments and Future Plans
2.7 Danaher Corporation
2.7.1 Danaher Corporation Details
2.7.2 Danaher Corporation Major Business
2.7.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Product and Solutions
2.7.4 Danaher Corporation Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Danaher Corporation Recent Developments and Future Plans
2.8 Johnson and Johnson
2.8.1 Johnson and Johnson Details
2.8.2 Johnson and Johnson Major Business
2.8.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product and Solutions
2.8.4 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Johnson and Johnson Recent Developments and Future Plans
2.9 Bayer Healthcare
2.9.1 Bayer Healthcare Details
2.9.2 Bayer Healthcare Major Business
2.9.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product and Solutions
2.9.4 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bayer Healthcare Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Point-of-care Molecular Diagnostic Solution Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Point-of-care Molecular Diagnostic Solution by Company Revenue
3.2.2 Top 3 Point-of-care Molecular Diagnostic Solution Players Market Share in 2022
3.2.3 Top 6 Point-of-care Molecular Diagnostic Solution Players Market Share in 2022
3.3 Point-of-care Molecular Diagnostic Solution Market: Overall Company Footprint Analysis
3.3.1 Point-of-care Molecular Diagnostic Solution Market: Region Footprint
3.3.2 Point-of-care Molecular Diagnostic Solution Market: Company Product Type Footprint
3.3.3 Point-of-care Molecular Diagnostic Solution Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Point-of-care Molecular Diagnostic Solution Consumption Value and Market Share by Type (2018-2023)
4.2 Global Point-of-care Molecular Diagnostic Solution Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2023)
5.2 Global Point-of-care Molecular Diagnostic Solution Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
6.2 North America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
6.3 North America Point-of-care Molecular Diagnostic Solution Market Size by Country
6.3.1 North America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2029)
6.3.2 United States Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
6.3.3 Canada Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
6.3.4 Mexico Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
7.2 Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
7.3 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country
7.3.1 Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2029)
7.3.2 Germany Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7.3.3 France Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7.3.5 Russia Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7.3.6 Italy Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region
8.3.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2018-2029)
8.3.2 China Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.3 Japan Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.4 South Korea Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.5 India Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.7 Australia Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
9.2 South America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
9.3 South America Point-of-care Molecular Diagnostic Solution Market Size by Country
9.3.1 South America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2029)
9.3.2 Brazil Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
9.3.3 Argentina Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country
10.3.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2029)
10.3.2 Turkey Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
10.3.4 UAE Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Point-of-care Molecular Diagnostic Solution Market Drivers
11.2 Point-of-care Molecular Diagnostic Solution Market Restraints
11.3 Point-of-care Molecular Diagnostic Solution Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Point-of-care Molecular Diagnostic Solution Industry Chain
12.2 Point-of-care Molecular Diagnostic Solution Upstream Analysis
12.3 Point-of-care Molecular Diagnostic Solution Midstream Analysis
12.4 Point-of-care Molecular Diagnostic Solution Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Point-of-care Molecular Diagnostic Solution
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Point-of-care Molecular Diagnostic Solution by Type
1.3.1 Overview: Global Point-of-care Molecular Diagnostic Solution Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type in 2022
1.3.3 Assays & kits
1.3.4 Instruments & Analyzers
1.3.5 Software & Services
1.4 Global Point-of-care Molecular Diagnostic Solution Market by Application
1.4.1 Overview: Global Point-of-care Molecular Diagnostic Solution Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Physicians’ Offices
1.4.3 Hospitals & ICUs
1.4.4 Research Institutes
1.4.5 Other End Users
1.5 Global Point-of-care Molecular Diagnostic Solution Market Size & Forecast
1.6 Global Point-of-care Molecular Diagnostic Solution Market Size and Forecast by Region
1.6.1 Global Point-of-care Molecular Diagnostic Solution Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Point-of-care Molecular Diagnostic Solution Market Size by Region, (2018-2029)
1.6.3 North America Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
1.6.4 Europe Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
1.6.6 South America Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product and Solutions
2.1.4 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche AG
2.2.1 F. Hoffmann-La Roche AG Details
2.2.2 F. Hoffmann-La Roche AG Major Business
2.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product and Solutions
2.2.4 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
2.3 Becton, Dickinson and Company
2.3.1 Becton, Dickinson and Company Details
2.3.2 Becton, Dickinson and Company Major Business
2.3.3 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product and Solutions
2.3.4 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Becton, Dickinson and Company Recent Developments and Future Plans
2.4 BioMerieux
2.4.1 BioMerieux Details
2.4.2 BioMerieux Major Business
2.4.3 BioMerieux Point-of-care Molecular Diagnostic Solution Product and Solutions
2.4.4 BioMerieux Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioMerieux Recent Developments and Future Plans
2.5 Bio-Rad Laboratories, Inc.
2.5.1 Bio-Rad Laboratories, Inc. Details
2.5.2 Bio-Rad Laboratories, Inc. Major Business
2.5.3 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product and Solutions
2.5.4 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.6 Cepheid, Inc.
2.6.1 Cepheid, Inc. Details
2.6.2 Cepheid, Inc. Major Business
2.6.3 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product and Solutions
2.6.4 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cepheid, Inc. Recent Developments and Future Plans
2.7 Danaher Corporation
2.7.1 Danaher Corporation Details
2.7.2 Danaher Corporation Major Business
2.7.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Product and Solutions
2.7.4 Danaher Corporation Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Danaher Corporation Recent Developments and Future Plans
2.8 Johnson and Johnson
2.8.1 Johnson and Johnson Details
2.8.2 Johnson and Johnson Major Business
2.8.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product and Solutions
2.8.4 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Johnson and Johnson Recent Developments and Future Plans
2.9 Bayer Healthcare
2.9.1 Bayer Healthcare Details
2.9.2 Bayer Healthcare Major Business
2.9.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product and Solutions
2.9.4 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bayer Healthcare Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Point-of-care Molecular Diagnostic Solution Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Point-of-care Molecular Diagnostic Solution by Company Revenue
3.2.2 Top 3 Point-of-care Molecular Diagnostic Solution Players Market Share in 2022
3.2.3 Top 6 Point-of-care Molecular Diagnostic Solution Players Market Share in 2022
3.3 Point-of-care Molecular Diagnostic Solution Market: Overall Company Footprint Analysis
3.3.1 Point-of-care Molecular Diagnostic Solution Market: Region Footprint
3.3.2 Point-of-care Molecular Diagnostic Solution Market: Company Product Type Footprint
3.3.3 Point-of-care Molecular Diagnostic Solution Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Point-of-care Molecular Diagnostic Solution Consumption Value and Market Share by Type (2018-2023)
4.2 Global Point-of-care Molecular Diagnostic Solution Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2023)
5.2 Global Point-of-care Molecular Diagnostic Solution Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
6.2 North America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
6.3 North America Point-of-care Molecular Diagnostic Solution Market Size by Country
6.3.1 North America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2029)
6.3.2 United States Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
6.3.3 Canada Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
6.3.4 Mexico Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
7.2 Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
7.3 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country
7.3.1 Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2029)
7.3.2 Germany Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7.3.3 France Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7.3.5 Russia Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
7.3.6 Italy Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region
8.3.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2018-2029)
8.3.2 China Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.3 Japan Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.4 South Korea Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.5 India Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
8.3.7 Australia Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
9.2 South America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
9.3 South America Point-of-care Molecular Diagnostic Solution Market Size by Country
9.3.1 South America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2029)
9.3.2 Brazil Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
9.3.3 Argentina Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country
10.3.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2029)
10.3.2 Turkey Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
10.3.4 UAE Point-of-care Molecular Diagnostic Solution Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Point-of-care Molecular Diagnostic Solution Market Drivers
11.2 Point-of-care Molecular Diagnostic Solution Market Restraints
11.3 Point-of-care Molecular Diagnostic Solution Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Point-of-care Molecular Diagnostic Solution Industry Chain
12.2 Point-of-care Molecular Diagnostic Solution Upstream Analysis
12.3 Point-of-care Molecular Diagnostic Solution Midstream Analysis
12.4 Point-of-care Molecular Diagnostic Solution Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 8. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche AG Major Business
Table 12. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 13. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. F. Hoffmann-La Roche AG Recent Developments and Future Plans
Table 15. Becton, Dickinson and Company Company Information, Head Office, and Major Competitors
Table 16. Becton, Dickinson and Company Major Business
Table 17. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 18. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Becton, Dickinson and Company Recent Developments and Future Plans
Table 20. BioMerieux Company Information, Head Office, and Major Competitors
Table 21. BioMerieux Major Business
Table 22. BioMerieux Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 23. BioMerieux Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. BioMerieux Recent Developments and Future Plans
Table 25. Bio-Rad Laboratories, Inc. Company Information, Head Office, and Major Competitors
Table 26. Bio-Rad Laboratories, Inc. Major Business
Table 27. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 28. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Table 30. Cepheid, Inc. Company Information, Head Office, and Major Competitors
Table 31. Cepheid, Inc. Major Business
Table 32. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 33. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Cepheid, Inc. Recent Developments and Future Plans
Table 35. Danaher Corporation Company Information, Head Office, and Major Competitors
Table 36. Danaher Corporation Major Business
Table 37. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 38. Danaher Corporation Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Danaher Corporation Recent Developments and Future Plans
Table 40. Johnson and Johnson Company Information, Head Office, and Major Competitors
Table 41. Johnson and Johnson Major Business
Table 42. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 43. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Johnson and Johnson Recent Developments and Future Plans
Table 45. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 46. Bayer Healthcare Major Business
Table 47. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 48. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bayer Healthcare Recent Developments and Future Plans
Table 50. Global Point-of-care Molecular Diagnostic Solution Revenue (USD Million) by Players (2018-2023)
Table 51. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Players (2018-2023)
Table 52. Breakdown of Point-of-care Molecular Diagnostic Solution by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Point-of-care Molecular Diagnostic Solution, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key Point-of-care Molecular Diagnostic Solution Players
Table 55. Point-of-care Molecular Diagnostic Solution Market: Company Product Type Footprint
Table 56. Point-of-care Molecular Diagnostic Solution Market: Company Product Application Footprint
Table 57. Point-of-care Molecular Diagnostic Solution New Market Entrants and Barriers to Market Entry
Table 58. Point-of-care Molecular Diagnostic Solution Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Point-of-care Molecular Diagnostic Solution Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global Point-of-care Molecular Diagnostic Solution Consumption Value Share by Type (2018-2023)
Table 61. Global Point-of-care Molecular Diagnostic Solution Consumption Value Forecast by Type (2024-2029)
Table 62. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023)
Table 63. Global Point-of-care Molecular Diagnostic Solution Consumption Value Forecast by Application (2024-2029)
Table 64. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 94. Point-of-care Molecular Diagnostic Solution Raw Material
Table 95. Key Suppliers of Point-of-care Molecular Diagnostic Solution Raw Materials
Table 1. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 8. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche AG Major Business
Table 12. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 13. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. F. Hoffmann-La Roche AG Recent Developments and Future Plans
Table 15. Becton, Dickinson and Company Company Information, Head Office, and Major Competitors
Table 16. Becton, Dickinson and Company Major Business
Table 17. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 18. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Becton, Dickinson and Company Recent Developments and Future Plans
Table 20. BioMerieux Company Information, Head Office, and Major Competitors
Table 21. BioMerieux Major Business
Table 22. BioMerieux Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 23. BioMerieux Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. BioMerieux Recent Developments and Future Plans
Table 25. Bio-Rad Laboratories, Inc. Company Information, Head Office, and Major Competitors
Table 26. Bio-Rad Laboratories, Inc. Major Business
Table 27. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 28. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Table 30. Cepheid, Inc. Company Information, Head Office, and Major Competitors
Table 31. Cepheid, Inc. Major Business
Table 32. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 33. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Cepheid, Inc. Recent Developments and Future Plans
Table 35. Danaher Corporation Company Information, Head Office, and Major Competitors
Table 36. Danaher Corporation Major Business
Table 37. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 38. Danaher Corporation Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Danaher Corporation Recent Developments and Future Plans
Table 40. Johnson and Johnson Company Information, Head Office, and Major Competitors
Table 41. Johnson and Johnson Major Business
Table 42. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 43. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Johnson and Johnson Recent Developments and Future Plans
Table 45. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 46. Bayer Healthcare Major Business
Table 47. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product and Solutions
Table 48. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bayer Healthcare Recent Developments and Future Plans
Table 50. Global Point-of-care Molecular Diagnostic Solution Revenue (USD Million) by Players (2018-2023)
Table 51. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Players (2018-2023)
Table 52. Breakdown of Point-of-care Molecular Diagnostic Solution by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Point-of-care Molecular Diagnostic Solution, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key Point-of-care Molecular Diagnostic Solution Players
Table 55. Point-of-care Molecular Diagnostic Solution Market: Company Product Type Footprint
Table 56. Point-of-care Molecular Diagnostic Solution Market: Company Product Application Footprint
Table 57. Point-of-care Molecular Diagnostic Solution New Market Entrants and Barriers to Market Entry
Table 58. Point-of-care Molecular Diagnostic Solution Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Point-of-care Molecular Diagnostic Solution Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global Point-of-care Molecular Diagnostic Solution Consumption Value Share by Type (2018-2023)
Table 61. Global Point-of-care Molecular Diagnostic Solution Consumption Value Forecast by Type (2024-2029)
Table 62. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023)
Table 63. Global Point-of-care Molecular Diagnostic Solution Consumption Value Forecast by Application (2024-2029)
Table 64. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa Point-of-care Molecular Diagnostic Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 94. Point-of-care Molecular Diagnostic Solution Raw Material
Table 95. Key Suppliers of Point-of-care Molecular Diagnostic Solution Raw Materials
LIST OF FIGURES
Figure 1. Point-of-care Molecular Diagnostic Solution Picture
Figure 2. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type in 2022
Figure 4. Assays & kits
Figure 5. Instruments & Analyzers
Figure 6. Software & Services
Figure 7. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application in 2022
Figure 9. Physicians’ Offices Picture
Figure 10. Hospitals & ICUs Picture
Figure 11. Research Institutes Picture
Figure 12. Other End Users Picture
Figure 13. Global Point-of-care Molecular Diagnostic Solution Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Point-of-care Molecular Diagnostic Solution Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Point-of-care Molecular Diagnostic Solution Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Region in 2022
Figure 18. North America Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Players in 2022
Figure 24. Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Point-of-care Molecular Diagnostic Solution Market Share in 2022
Figure 26. Global Top 6 Players Point-of-care Molecular Diagnostic Solution Market Share in 2022
Figure 27. Global Point-of-care Molecular Diagnostic Solution Consumption Value Share by Type (2018-2023)
Figure 28. Global Point-of-care Molecular Diagnostic Solution Market Share Forecast by Type (2024-2029)
Figure 29. Global Point-of-care Molecular Diagnostic Solution Consumption Value Share by Application (2018-2023)
Figure 30. Global Point-of-care Molecular Diagnostic Solution Market Share Forecast by Application (2024-2029)
Figure 31. North America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 41. France Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Region (2018-2029)
Figure 48. China Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 51. India Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 65. Point-of-care Molecular Diagnostic Solution Market Drivers
Figure 66. Point-of-care Molecular Diagnostic Solution Market Restraints
Figure 67. Point-of-care Molecular Diagnostic Solution Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Point-of-care Molecular Diagnostic Solution in 2022
Figure 70. Manufacturing Process Analysis of Point-of-care Molecular Diagnostic Solution
Figure 71. Point-of-care Molecular Diagnostic Solution Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Point-of-care Molecular Diagnostic Solution Picture
Figure 2. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type in 2022
Figure 4. Assays & kits
Figure 5. Instruments & Analyzers
Figure 6. Software & Services
Figure 7. Global Point-of-care Molecular Diagnostic Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application in 2022
Figure 9. Physicians’ Offices Picture
Figure 10. Hospitals & ICUs Picture
Figure 11. Research Institutes Picture
Figure 12. Other End Users Picture
Figure 13. Global Point-of-care Molecular Diagnostic Solution Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Point-of-care Molecular Diagnostic Solution Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Point-of-care Molecular Diagnostic Solution Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Region in 2022
Figure 18. North America Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Players in 2022
Figure 24. Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Point-of-care Molecular Diagnostic Solution Market Share in 2022
Figure 26. Global Top 6 Players Point-of-care Molecular Diagnostic Solution Market Share in 2022
Figure 27. Global Point-of-care Molecular Diagnostic Solution Consumption Value Share by Type (2018-2023)
Figure 28. Global Point-of-care Molecular Diagnostic Solution Market Share Forecast by Type (2024-2029)
Figure 29. Global Point-of-care Molecular Diagnostic Solution Consumption Value Share by Application (2018-2023)
Figure 30. Global Point-of-care Molecular Diagnostic Solution Market Share Forecast by Application (2024-2029)
Figure 31. North America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 41. France Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Region (2018-2029)
Figure 48. China Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 51. India Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Point-of-care Molecular Diagnostic Solution Consumption Value (2018-2029) & (USD Million)
Figure 65. Point-of-care Molecular Diagnostic Solution Market Drivers
Figure 66. Point-of-care Molecular Diagnostic Solution Market Restraints
Figure 67. Point-of-care Molecular Diagnostic Solution Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Point-of-care Molecular Diagnostic Solution in 2022
Figure 70. Manufacturing Process Analysis of Point-of-care Molecular Diagnostic Solution
Figure 71. Point-of-care Molecular Diagnostic Solution Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
